Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder

World Journal of Urology

Volumn 31, Issue 5, 2013, Pages 1029-1036

  Kluth, Luis A ^a,c   Fajkovic, Harun ^a,d   Xylinas, Evanguelos ^a,e   Crivelli, Joseph J ^a   Passoni, Niccolo ^f   Rouprêt, Morgan ^a,g   Becker, Andreas ^c,h   Comploj, Evi ⁱ   Pycha, Armin ⁱ   Holmang, Sten ^j   Gupta, Amit ^k   Lotan, Yair ^l   Karakiewicz, Pierre I ^h   Gontero, Paolo ^m   Chun, Felix K H ^c   Fisch, Margit ^c   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^e Paris Descartes University ^*  (France)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ CENTRAL HOSPITAL OF BOLZANO   (Italy)

^j SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^k UNIVERSITY OF IOWA   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m MOLINETTE HOSPITAL   (Italy)

more..

Author keywords

Bladder carcinoma; Disease recurrence; Gender; T1 urothelial cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BLADDER TUMOR; CANCER GRADING; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; VERY ELDERLY;

ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84884815360     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0996-9     Document Type: Article

References (27)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer JClin 62: 10-29.
2. Babjuk M, Oosterlinck W, Sylvester R et al (2011) European Association of Urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59: 997-1008.
3. Fernandez-Gomez J, Madero R, Solsona E et al (2009) Predicting non-muscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol 182: 2195-2203.
4. Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2, 596 patients from seven EORTC trials. Eur Urol 49: 466-475.
5. Fajkovic H, Halpern JA, Cha EK et al (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4): 457-463.
6. NCCN clinical practice guidelines in oncology: bladder cancer 2011. National Comprehensive Cancer Network Web site. http://www. nccn. org/professionals/physician_gls/f_guidelines. asp.
7. Rink M, Fajkovic H, Cha EK et al (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61: 854-855.
8. Jeldres C, Isbarn H, Capitanio U et al (2009) Gender is an important predictor of cancer-specific survival in patients with urothelial carcinoma after radical cystectomy (abstract #1761). J Urol 181: 635.
9. Datta GD, Neville B, Datta NS, Earle C (2006) Gender disparities in bladder cancer survival: an assessment of sociodemographic factors. AACR Meet Abstract 2006: B38.
10. Tilki D, Reich O, Svatek RS et al (2010) Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol 183: 1757-1763.
11. Tilki D, Svatek RS, Novara G et al (2010) Stage pT0 at radical cystectomy confers improved survival: an international study of 4, 430 patients. J Urol 184: 888-894.
12. Tilki D, Svatek RS, Karakiewicz PI et al (2010) Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 183: 87-93.
13. Zhuang YH, Blauer M, Tammela T et al (1997) Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology 30: 556-562.
14. Boorjian S, Ugras S, Mongan NP et al (2004) Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64: 383-388.
15. Shen SS, Smith CL, Hsieh JT et al (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer 106: 2610-2616.
16. Saez S, Martin PM (1981) Evidence of estrogen receptors in the trigonearea of human urinary bladder. J Steroid Biochem 15: 317-320.
17. McGrath M, Michaud DS, De Vivo I (2006) Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163: 236-244.
18. Boorjian SA, Zhu F, Herr HW (2010) The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU Int 106(3): 357-361.
19. Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA (2000) Gender differences in stage distribution of bladder cancer. Urology 55: 368-371.
20. Micheli A, Mariotto A, Rossi AG et al (1998) The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 34: 2271-2278.
21. Kiemeney LALM, Coebergh JWW, Koper NP et al (1994) Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975-1989. Eur J Cancer 30A: 1134-1137.
22. Fleshner NE, Herr HW, Stewart AK et al (1996) For the American College of Surgeons on Cancer and the American Cancer Society: the National Data Base Report on bladder carcinoma. Cancer 78: 1505-1509.
23. Mungan NA, Aben KK, Schoenberg MP et al (2000) Gender differences in stage-adjusted bladder cancer survival. Urology 55: 876-880.
24. Puente D, Malats N, Cecchini L et al (2003) Gender-related divergence in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 43: 53-62.
25. Palou J, Sylvester RJ, Faba OR, Parada R, Peña JA, Algaba F, (2012) Villavicencio H. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin. Eur Urol 62(1): 118-125. Epub 2011 Oct 25.
26. Shariat SF, Svatek RS, Tilki D et al (2010) International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 105(10): 1402-1412.
27. Rink M, Robinson BD, Green DA et al (2012) Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188(2): 398-404.